These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15780633

  • 21. Increased bioavailability of tricin-amino acid derivatives via a prodrug approach.
    Ninomiya M, Tanaka K, Tsuchida Y, Muto Y, Koketsu M, Watanabe K.
    J Med Chem; 2011 Mar 10; 54(5):1529-36. PubMed ID: 21319803
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
    Kaptein SJ, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, Bruggeman CA, Vink C, Stamminger T, Marschall M.
    Antiviral Res; 2006 Feb 10; 69(2):60-9. PubMed ID: 16325931
    [Abstract] [Full Text] [Related]

  • 27. Antiviral drugs for cytomegalovirus diseases.
    Biron KK.
    Antiviral Res; 2006 Sep 10; 71(2-3):154-63. PubMed ID: 16765457
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prediction of drug bioavailability in humans using immobilized artificial membrane phosphatidylcholine column chromatography and in vitro hepatic metabolic clearance.
    Shin BS, Yoon CH, Balthasar JP, Choi BY, Hong SH, Kim HJ, Lee JB, Hwang SW, Yoo SD.
    Biomed Chromatogr; 2009 Jul 10; 23(7):764-9. PubMed ID: 19296531
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Synthesis and anti-HCMV activity of novel 5'-norcarboacyclic nucleosides.
    Kim A, Hong JH.
    Arch Pharm (Weinheim); 2005 Nov 10; 338(11):522-7. PubMed ID: 16281312
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A, Champier G, Alain S, Petit F, Le Pors MJ, Mazeron MC.
    Antivir Ther; 2006 Nov 10; 11(4):537-40. PubMed ID: 16856628
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Discovery of a novel series of inhibitors of human cytomegalovirus primase.
    Cushing TD, Adrian J, Chen X, DiMaio H, Doughan B, Flygare J, Liang L, Mayorga V, Miao S, Mellon H, Peterson MG, Powers JP, Spector F, Stein C, Wright M, Xu D, Ye Q, Jaen J.
    Bioorg Med Chem Lett; 2006 Sep 15; 16(18):4879-83. PubMed ID: 16814545
    [Abstract] [Full Text] [Related]

  • 39. Development of predictive quantitative retention-activity relationship models of HMG-CoA reductase inhibitors by biopartitioning micellar chromatography.
    Wang SR, Chen Y, Wu LP, Miao WJ, Xiong MJ, Chen C, Zhong ZR, Ye LM.
    J Pharm Biomed Anal; 2008 Jan 22; 46(2):243-9. PubMed ID: 18024049
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.